Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors

SARS-CoV-2 serologic surveys estimate the proportion of the population with antibodies against historical variants, which nears 100% in many settings. New approaches are required to fully exploit serosurvey data. Using a SARS-CoV-2 anti-Spike (S) protein chemiluminescent microparticle assay, we atta...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lewis Buss, Carlos A. Prete, Charles Whittaker, Tassila Salomon, Marcio K. Oikawa, Rafael H. M. Pereira, Isabel C. G. Moura, Lucas Delerino, Rafael F. O. Franca, Fabio Miyajima, Alfredo Mendrone Jr., Cesar Almeida-Neto, Nanci A. Salles, Suzete C. Ferreira, Karine A. Fladzinski, Luana M. de Souza, Luciane K. Schier, Patricia M. Inoue, Lilyane A. Xabregas, Myuki A. E. Crispim, Nelson Fraiji, Luciana M. B. Carlos, Veridiana Pessoa, Maisa A. Ribeiro, Rosenvaldo E. de Souza, Anna F. Cavalcante, Maria I. B. Valença, Maria V. da Silva, Esther Lopes, Luiz A. Filho, Sheila O. G. Mateos, Gabrielle T. Nunes, David Schlesinger, Sônia Mara Nunes da Silva, Alexander L. Silva-Junior, Marcia C. Castro, Vítor H. Nascimento, Christopher Dye, Michael P. Busch, Nuno R. Faria, Ester C. Sabino
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-08-01
Col·lecció:	Vaccines
Matèries:	SARS-CoV-2 seroprevalence variants of concern immunity vaccines delta
Accés en línia:	https://www.mdpi.com/2076-393X/10/9/1437
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!